GNBT Secures $3.6M Capital

Generex Biotechnology Corporation (OTCBB: GNBT) announced today that it has secured two commitments for an aggregate capital raise of CA$3,600,000. This funding is structured as term loans of one year from private lenders secured by the Company’s real estate. Interest on the loans is payable monthly at the rate of 10% per annum.

This capital infusion will permit ...

Continue Reading →
0